Cargando…
Cryptosporidium parvum vaccine candidates are incompletely modified with O-linked-N-acetylgalactosamine or contain N-terminal N-myristate and S-palmitate
Cryptosporidium parvum (studied here) and Cryptosporidium hominis are important causes of diarrhea in infants and immunosuppressed persons. C. parvum vaccine candidates, which are on the surface of sporozoites, include glycoproteins with Ser- and Thr-rich domains (Gp15, Gp40, and Gp900) and a low co...
Autores principales: | Haserick, John R., Klein, Joshua A., Costello, Catherine E., Samuelson, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549699/ https://www.ncbi.nlm.nih.gov/pubmed/28792526 http://dx.doi.org/10.1371/journal.pone.0182395 |
Ejemplares similares
-
Regulatory Changes of N-Acetylgalactosamine Terminal Sugar in Early Mouse Embryonic Paraxial Mesenchyme
por: Hassanzadeh Taheri, Mohammad Mehdi, et al.
Publicado: (2012) -
Liver-Targeted Delivery of Oligonucleotides with N-Acetylgalactosamine Conjugation
por: Cui, Hao, et al.
Publicado: (2021) -
The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates
por: Zhang, Lei, et al.
Publicado: (2022) -
The Cryptosporidium parvum Kinome
por: Artz, Jennifer D, et al.
Publicado: (2011) -
A biologically active peptide mimetic of N-acetylgalactosamine/galactose
por: Eggink, Laura L, et al.
Publicado: (2009)